Key result
In rats with isoproterenol-induced cardiac injury, pimobendan increased type I collagen deposition while sildenafil attenuated it.
Why the study?
Regulators of cyclic nucleotide signaling are under investigation to modulate collagen deposition during myocardial healing, but the effects of PDE3 and PDE5 inhibitors needed evaluation.
Do phosphodiesterase type 3 (pimobendan) and type 5 (sildenafil) inhibitors improve cardiac function and reduce interstitial fibrosis in rats with isoproterenol-induced cardiac dysfunction?
Do phosphodiesterase type 3 (pimobendan) and type 5 (sildenafil) inhibitors improve cardiac function and reduce interstitial fibrosis in rats with isoproterenol-induced cardiac dysfunction?
In a rat model of catecholamine-induced myocardial injury, PDE5 inhibition (sildenafil) reduced fibrosis and improved diastolic function, whereas PDE3 inhibition (pimobendan) worsened fibrosis and diastolic dysfunction.
Answers are grounded in this paper and cite their sources.
PDE3 inhibition may worsen fibrosis in catecholamine injury models; leaves open PDE5 inhibition as antifibrotic strategy for clinical investigation.
Myocardial relaxation and stiffness are influenced by fibrillar collagen content. Cyclic nucleotide signaling regulators have been investigated targeting more effective modulation of collagen deposition during myocardial healing process. To assess the effects of phosphodiesterase type 3 and phosphodiesterase type 5 inhibitors on cardiac function and left ventricular myocardial fibrosis in catecholamine-induced myocardial injury, sildenafil and pimobendan were administered to male Wistar rats 24 hours after isoproterenol injection. Echocardiography and electrocardiogram were performed to assess kinetic and rhythm changes during 45 days of drug administration. At the end of study, type I and type III collagen were measured through immunohistochemistry analysis, and left ventricular pressure was assessed through invasive method. Echocardiography assessment showed increased relative wall thickness at 45 days in pimobendan group with significant diastolic dysfunction and increased collagen I deposition compared with nontreated positive group (3.03 ± 0.31 vs. 2.73 ± 0.28%, P < 0.05). Diastolic pressure correlated positively with type I collagen (r = 0.54, P < 0.05). Type III collagen analysis did not demonstrate difference among the groups. Sildenafil administration attenuated type I collagen deposition (2.15 ± 0.51 vs. positive group, P < 0.05) and suggested to be related to arrhythmic events. Arrhythmic events were not related to the quantity of fibrillar collagen deposition. Although negative modulation of collagen synthesis through cyclic nucleotides signaling have shown promising results, in this study, pimobendan postconditioning resulted in increased collagen type I formation and severe diastolic dysfunction while sildenafil postconditioning reduced collagen type I deposition and attenuated diastolic dysfunction.
No takes yet. Share an insight, caveat, or question.
Nakata et al. (2019) studied Isoproterenol-induced cardiac dysfunction. Pimobendan and Sildenafil vs. Nontreated positive group was evaluated on Type I collagen deposition (p=<0.05). In rats with isoproterenol-induced cardiac injury, pimobendan increased type I collagen deposition while sildenafil attenuated it.
Synapse has enriched 10 related papers. Consider them for comparative context: